4-[2-(8-Hydroxy-7,8-dihydro-6H-imidazo[4,5-d][1,3]diazepin-3-yl)-ethyl]-naphthalene-2-carboxylic acid methyl ester

ID: ALA157951

PubChem CID: 10713804

Max Phase: Preclinical

Molecular Formula: C20H20N4O3

Molecular Weight: 364.41

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  COC(=O)c1cc(CCn2cnc3c2NC=NCC3O)c2ccccc2c1

Standard InChI:  InChI=1S/C20H20N4O3/c1-27-20(26)15-8-13-4-2-3-5-16(13)14(9-15)6-7-24-12-23-18-17(25)10-21-11-22-19(18)24/h2-5,8-9,11-12,17,25H,6-7,10H2,1H3,(H,21,22)

Standard InChI Key:  SULFMPMRSCCZRA-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 27 30  0  0  0  0  0  0  0  0999 V2000
    3.0917   -1.3417    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.5292   -1.7542    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.3375   -0.7917    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.0625   -1.4500    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.4917   -2.3417    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    3.9292   -0.8542    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.6667   -1.7667    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.6292   -1.7667    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.2042   -1.4750    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5000   -1.4375    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.1500   -1.4625    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.6667   -2.3667    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.0042   -2.6917    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.1417   -2.6667    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.6292   -2.3667    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4167   -2.5167    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.5875   -1.7625    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.1042   -1.4542    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.2167   -0.8667    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    7.7250   -1.7875    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.1542   -0.9292    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.2125   -1.9625    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.1375   -3.2750    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.1000   -2.6667    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.7167   -2.3917    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.6167   -3.5792    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.1000   -3.2667    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  2  0
  3  1  1  0
  4  2  1  0
  5  2  1  0
  6  3  2  0
  7 11  2  0
  8 18  1  0
  9  7  1  0
 10  1  1  0
 11  8  1  0
 12 14  2  0
 13  5  1  0
 14 15  1  0
 15  8  2  0
 16 22  1  0
 17  4  1  0
 18 17  1  0
 19  9  2  0
 20  9  1  0
 21 10  1  0
 22 10  1  0
 23 14  1  0
 24 15  1  0
 25 20  1  0
 26 27  1  0
 27 24  2  0
  6  4  1  0
 13 16  2  0
 12  7  1  0
 23 26  2  0
M  END

Associated Targets(Human)

AMPD3 Tchem AMP deaminase 3 (49 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

ADA Adenosine deaminase (739 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Biocomponents

Calculated Properties

Molecular Weight: 364.41Molecular Weight (Monoisotopic): 364.1535AlogP: 2.55#Rotatable Bonds: 4
Polar Surface Area: 88.74Molecular Species: NEUTRALHBA: 7HBD: 2
#RO5 Violations: HBA (Lipinski): 7HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: 13.06CX Basic pKa: 6.50CX LogP: 1.95CX LogD: 1.90
Aromatic Rings: 3Heavy Atoms: 27QED Weighted: 0.69Np Likeness Score: -0.23

References

1. Kasibhatla SR, Bookser BC, Xiao W, Erion MD..  (2001)  AMP deaminase inhibitors. 5. Design, synthesis, and SAR of a highly potent inhibitor series.,  44  (4): [PMID:11170651] [10.1021/jm000355t]

Source